DERM · TickerCove

DERMJourney Medical CorporationHealthcare · Drug Manufacturers - Specialty & Genericas of 2026-09-16

Horizon

Issued 2026-09-16 at $7.29 · now $7.29 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, DERM has typically landed between $5.06 and $10.24 — a range of −30.6% to +40.4% from the issuance price $7.29.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

1,193 overlapping 1 month windows · 2021-11-12 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($7.29) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$7.29 · 60% of range

$4.39 low$9.26 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

+0.1%

typical move · IQR 26.5%

−30.6%worst (p90)+40.4%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where DERM has typically landed a month from the 2026-09-16 close of $7.29 — the range is history, not a prediction.

now $7.29 (+0.0%)
typical $7.3 (+0.1%)
middle 50% $6.34–$8.27
90% range $5.06–$10.24

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,193 windows spanning 2021-11-12 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2026-02-26	−47.4%	−47.4%	+0.0%
2026-02-27	−46.3%	−46.3%	+0.1%
2026-02-25	−45.2%	−45.2%	+0.0%
3 best
2022-12-20	+106.7%	−4.2%	+113.4%
2023-05-18	+101.9%	+0.0%	+119.4%
2023-11-07	+94.8%	+0.0%	+94.8%

1,193 overlapping windows · 2021-11-12 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~5 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

60%

+5.5%

n=5

Feb

20%

−5.7%

n=5

Mar

20%

−11.2%

n=5

Apr

80%

+5.1%

n=5

May

80%

+1.3%

n=5

Jun

60%

+15.0%

n=5

Jul

40%

+2.4%

n=5

Aug

40%

+1.2%

n=5

Sep

40%

+2.2%

n=5

Oct

75%

+7.8%

n=4

Nov

50%

+1.5%

n=4

Dec

40%

−5.4%

n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2025-05-02	Maraoui Claude	director	Sale	4,834 @ $6.84	$33K	−0.2% of holding	−2.8%	−5.5%	2,348,313	Form 4 · filed 3 days after the trade
2025-05-02	Alloush Ramsey	officer	Sale	2,857 @ $6.84	$20K	−0.6% of holding	−2.8%	−5.5%	504,817	Form 4 · filed 3 days after the trade
2025-05-02	Benesch Joseph	officer	Sale	2,409 @ $6.84	$16K	−1.2% of holding	−2.8%	−5.5%	203,557	Form 4 · filed 3 days after the trade
2025-03-11	Maraoui Claude	director	Sale	49,271 @ $5.01	$247K	−2.4% of holding	+28.0%	+22.4%	2,003,147	Form 4 · filed same day
2025-03-07	Maraoui Claude	director	Sale	14,905 @ $5.01	$75K	−0.7% of holding	+47.6%	+23.0%	2,052,418	Form 4 · filed 3 days after the trade
2025-03-06	Maraoui Claude	director	Sale	25,551 @ $5.04	$129K	−1.2% of holding	+53.6%	+24.9%	2,067,323	Form 4 · filed 4 days after the trade
2025-03-05	Maraoui Claude	director	Sale	18,147 @ $5.13	$93K	−0.9% of holding	+33.7%	+23.0%	2,092,874	Form 4 · filed same day
2025-03-04	Maraoui Claude	director	Sale	28,901 @ $5.04	$146K	−1.4% of holding	+24.7%	+24.6%	2,111,021	Form 4 · filed 1 day after the trade
2025-03-03	Maraoui Claude	director	Sale	23,508 @ $5.19	$122K	−1.1% of holding	+21.8%	+30.7%	2,139,922	Form 4 · filed 2 days after the trade
2025-02-21	Benesch Joseph	officer	Sale	1,365 @ $5.19	$7K	−2.9% of holding	+30.0%	+35.7%	45,966	Form 4 · filed 3 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

37 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-07-01	Smith Justin Adam	director	Award / grant	50,000	231,618	Form 4
2026-07-01	Toledano Miranda Jayne	director	Award / grant	50,000	168,618	Form 4
2026-07-01	Herskowitz Neil	director	Award / grant	50,000	168,618	Form 4
2026-06-25	ROSENWALD LINDSAY A MD	director	Award / grant	10,000	221,146	Form 4
2026-06-25	Pearce Michael Cooper	director	Award / grant	10,000	67,173	Form 4
2026-06-25	Smith Justin Adam	director	Award / grant	10,000	181,618	Form 4
2026-06-25	Toledano Miranda Jayne	director	Award / grant	10,000	118,618	Form 4
2026-06-25	Herskowitz Neil	director	Award / grant	10,000	118,618	Form 4
2026-04-22	Benesch Joseph	officer	Award / grant	41,860	41,860	Form 4
2026-04-22	Maraoui Claude	director	Award / grant	49,277	2,435,990	Form 4
2026-04-22	Maraoui Claude	director	Award / grant	82,915	82,915	Form 4
2026-04-22	Benesch Joseph	officer	Award / grant	28,907	261,371	Form 4
2026-04-22	Alloush Ramsey	officer	Award / grant	46,863	598,543	Form 4
2026-04-22	Alloush Ramsey	officer	Award / grant	62,795	62,795	Form 4
2025-08-25	Maraoui Claude	director	Withheld for tax	10,877	2,386,713	Form 4
2025-08-25	Maraoui Claude	director	Option exercise	1,250,000	2,397,590	Form 4
2025-08-25	Maraoui Claude	director	Option exercise	1,250,000	0	Form 4
2025-08-05	Toledano Miranda Jayne	director	Award / grant	20,000	108,618	Form 4
2025-08-05	ROSENWALD LINDSAY A MD	director	Award / grant	50,000	211,146	Form 4
2025-08-05	Smith Justin Adam	director	Award / grant	20,000	171,618	Form 4
2025-08-05	Herskowitz Neil	director	Award / grant	20,000	108,618	Form 4
2025-08-05	Pearce Michael Cooper	director	Award / grant	20,000	57,173	Form 4
2025-06-25	Pearce Michael Cooper	director	Award / grant	7,173	37,173	Form 4
2025-06-25	Smith Justin Adam	director	Award / grant	7,173	151,618	Form 4
2025-06-25	Herskowitz Neil	director	Award / grant	7,173	88,618	Form 4
2025-06-25	ROSENWALD LINDSAY A MD	director	Award / grant	7,173	161,146	Form 4
2025-06-25	Toledano Miranda Jayne	director	Award / grant	7,173	88,618	Form 4
2025-06-17	Maraoui Claude	director	Award / grant	49,277	2,397,590	Form 4
2025-06-17	Maraoui Claude	director	Award / grant	82,915	82,915	Form 4
2025-06-17	Benesch Joseph	officer	Award / grant	28,907	232,464	Form 4
2025-06-17	Benesch Joseph	officer	Award / grant	41,860	41,860	Form 4
2025-06-17	Alloush Ramsey	officer	Award / grant	46,863	551,680	Form 4
2025-06-17	Alloush Ramsey	officer	Award / grant	62,795	62,795	Form 4
2024-05-01	Benesch Joseph	officer	Award / grant	80,000	205,966	Form 4
2024-05-01	Maraoui Claude	director	Award / grant	175,000	2,353,147	Form 4
2024-01-03	Benesch Joseph	officer	Award / grant	80,000	125,966	Form 4
2024-01-03	Maraoui Claude	director	Award / grant	175,000	2,178,147	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

27d remaining

2026-09-174% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i